Clinical trial
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control…
NCT00421863 · Heart Care Foundation, Other · Completed
Key facts
| NCT number | NCT00421863 |
|---|---|
| Title | Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study |
| Official title | Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study |
| Lead sponsor | Heart Care Foundation, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Triatec 10 mg, Triatec HCT 5, Lasix 25, Micardis 80 mg, Micardis plus 80/12.5, Catapresan TTS 2, Norvasc 10 mg, Triatec 5 mg, Pluscor |
| Enrollment | 1,111 |
| Start date | Feb 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 15, 2007 |
| Last update posted | Feb 3, 2021 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: